MUFG Securities EMEA plc purchased a new position in Monsanto Company (NYSE:MON) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 113,000 shares of the basic materials company’s stock, valued at approximately $13,375,000. Monsanto makes up 0.5% of MUFG Securities EMEA plc’s investment portfolio, making the stock its 26th biggest holding.

Several other large investors have also added to or reduced their stakes in MON. Acrospire Investment Management LLC bought a new position in shares of Monsanto in the first quarter worth $113,000. Pinnacle Financial Partners Inc. bought a new position in shares of Monsanto in the second quarter worth $114,000. JNBA Financial Advisors grew its stake in shares of Monsanto by 3.9% in the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock worth $135,000 after purchasing an additional 45 shares in the last quarter. Armbruster Capital Management Inc. grew its stake in shares of Monsanto by 12.2% in the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock worth $136,000 after purchasing an additional 125 shares in the last quarter. Finally, Penserra Capital Management LLC grew its stake in shares of Monsanto by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,288 shares of the basic materials company’s stock worth $145,000 after purchasing an additional 112 shares in the last quarter. 74.79% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This story was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.thecerbatgem.com/2017/09/13/113000-shares-in-monsanto-company-mon-acquired-by-mufg-securities-emea-plc.html.

Shares of Monsanto Company (NYSE:MON) opened at 117.44 on Wednesday. Monsanto Company has a one year low of $97.35 and a one year high of $118.97. The stock has a market capitalization of $51.59 billion, a P/E ratio of 25.37 and a beta of 1.07. The stock’s 50 day moving average price is $117.21 and its 200 day moving average price is $116.36.

Monsanto (NYSE:MON) last posted its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.19. The company had revenue of $4.23 billion during the quarter, compared to analysts’ expectations of $4.18 billion. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. Monsanto’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period last year, the company posted $2.17 earnings per share. On average, analysts forecast that Monsanto Company will post $4.89 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be paid a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 annualized dividend and a yield of 1.84%. Monsanto’s payout ratio is 46.75%.

MON has been the subject of several recent analyst reports. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price target for the company in a research note on Friday, June 16th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target for the company in a research note on Wednesday, July 12th. Piper Jaffray Companies set a $128.00 price target on Monsanto and gave the stock a “buy” rating in a research note on Friday, August 11th. BMO Capital Markets reissued a “buy” rating and issued a $128.00 price target on shares of Monsanto in a research note on Friday, September 1st. Finally, Barclays PLC increased their price target on Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Thursday, June 29th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and eight have issued a buy rating to the company. The company has an average rating of “Hold” and an average price target of $123.43.

In related news, EVP Robert T. Fraley sold 52,410 shares of the firm’s stock in a transaction on Monday, July 10th. The shares were sold at an average price of $117.95, for a total transaction of $6,181,759.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Steven Mizell sold 11,300 shares of the firm’s stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the transaction, the executive vice president now directly owns 55,011 shares of the company’s stock, valued at $6,522,654.27. The disclosure for this sale can be found here. Company insiders own 0.79% of the company’s stock.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.